• Oct 20, 2022 from 1:00 to 2:30
  • Location: Online Event
  • Latest Activity: Oct 12, 2022

FDA requires that all computer systems used to produce, manage and report on “GxP” (GMP, GLC, GCP) related products be validated and maintained in accordance with specific rules.  This webinar will help you understand the FDA’s current thinking on computer systems that are validated and subject to inspection and audit.  It will also take into account areas where FDA will likely focus its effort, including the higher-risk systems.

As a “GxP” system, following Good Manufacturing, Laboratory, and Clinical Practices, the computer system must be validated in accordance with FDA requirements.  If electronic records and/or electronic signatures (ER/ES) are incorporated into the system, FDA’s CFR Part 11 guidance on ER/ES must be followed.

This webinar will focus on the key areas that are most important, including security and data integrity.  Implementing and following the System Development Life Cycle (SDLC) methodology is the best approach for computer system validation and maintaining data integrity.  The life cycle approach takes all aspects of validation into account throughout the life of the system and the data that it houses.  The data is a key asset for any FDA-regulated company and must be protected through its entire retention period.

In preparation for an audit, it is important to assess the documentation that was prepared when each GxP system was validated to identify and remediate any gaps or issues.  The FDA contact person(s) should be able to tell the story of how each system came into Production in a validated state and how each system is maintained in that validated state with the data integrity assured.

It’s important to have the right resources and understanding of the process prior to any inspection.  Having the validation information available and key resources who can speak to various components of it is critical and should be arranged in advance.
You will learn some tips based on real FDA inspections and lessons learned that will be shared with the audience.

WHY SHOULD YOU ATTEND?

FDA requires that all computer systems that handle data regulated by the Agency be validated in accordance with their guidance on computerized systems. In 1997, 21 CFR Part 11 was issued to address electronic records and signatures, as many laboratories and other FDA-regulated organizations began seeking ways to move into a paperless environment.  This guidance has been modified over the years to make it more palatable to the industry, and this includes discretionary enforcement measures.  The intent was to avoid creating a huge regulatory compliance cost to the industry that was initially preventing companies from embracing the technology.

This session will provide some insight into current trends in compliance and enforcement that can help in preparation for an FDA inspection or audit of computer systems that are regulated.  There are some key areas of focus that will be covered that will help you to plan for an on-site inspection.

LEARNING OBJECTIVES

  • Computer System Validation (CSV) and the System Development Life Cycle (SDLC) Methodology
  • “GxP” – Good Manufacturing, Laboratory, and Clinical Practices
  • 21 CFR Part 11, Electronic Records/Electronic Signatures (ER/ES)
  • Data Archival to ensure security, integrity, and compliance
  • Validation Strategy that will take into account the system risk assessment and system categorization (GAMP V) processes
  • Recent FDA findings for companies in regulated industries
  • The resources, documentation, and room preparation necessary to adequately prepare for inspection
  • Q&A

WHO WILL BENEFIT?

  • Information Technology Analysts
  • QC/QA Managers
  • QC/QA Analysts
  • Clinical Data Managers
  • Clinical Data Scientists
  • Analytical Chemists
  • Compliance Managers
  • Laboratory Managers
  • Automation Analysts
  • Manufacturing Managers
  • Manufacturing Supervisors
  • Supply Chain Specialists
  • Computer System Validation Specialists
  • GMP Training Specialists
  • Auditors engaged in the internal inspection of labeling records and practices
  • Business Stakeholders responsible for computer system validation planning, execution, reporting, compliance, maintenance, and audit
  • Consultants working in the life sciences industry who are involved in computer system implementation, validation, and compliance

More Info  :  https://247compliance.us/best-practices-for-preparing-for-an-fda-computer-system-audit/1879?through=Samir12thOctLI&sm_grc

Contact :  +1-661-336-9555
                 info@247compliance.us

E-mail me when people leave their comments –

You need to be a member of Global Risk Community to add comments!

Join Global Risk Community

Upcoming Featured events

    About Us

    The GlobalRisk Community is a thriving community of risk managers and associated service providers. Our purpose is to foster business, networking and educational explorations among members. Our goal is to be the worlds premier Risk forum and contribute to better understanding of the complex world of risk.

    Business Partners

    For companies wanting to create a greater visibility for their products and services among their prospects in the Risk market: Send your business partnership request by filling in the form here!

lead